JP2011517689A5 - - Google Patents

Download PDF

Info

Publication number
JP2011517689A5
JP2011517689A5 JP2011504377A JP2011504377A JP2011517689A5 JP 2011517689 A5 JP2011517689 A5 JP 2011517689A5 JP 2011504377 A JP2011504377 A JP 2011504377A JP 2011504377 A JP2011504377 A JP 2011504377A JP 2011517689 A5 JP2011517689 A5 JP 2011517689A5
Authority
JP
Japan
Prior art keywords
quinolin
yloxy
phenyl
fluoro
dimethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011504377A
Other languages
English (en)
Japanese (ja)
Other versions
JP5746015B2 (ja
JP2011517689A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/002798 external-priority patent/WO2009127417A1/en
Publication of JP2011517689A publication Critical patent/JP2011517689A/ja
Publication of JP2011517689A5 publication Critical patent/JP2011517689A5/ja
Application granted granted Critical
Publication of JP5746015B2 publication Critical patent/JP5746015B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011504377A 2008-04-16 2009-04-16 Axlキナーゼ阻害剤としてのキノリン誘導体 Active JP5746015B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4539808P 2008-04-16 2008-04-16
US61/045,398 2008-04-16
PCT/EP2009/002798 WO2009127417A1 (en) 2008-04-16 2009-04-16 Quinoline derivatives as axl kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2011517689A JP2011517689A (ja) 2011-06-16
JP2011517689A5 true JP2011517689A5 (cg-RX-API-DMAC7.html) 2012-05-31
JP5746015B2 JP5746015B2 (ja) 2015-07-08

Family

ID=40999731

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011504377A Active JP5746015B2 (ja) 2008-04-16 2009-04-16 Axlキナーゼ阻害剤としてのキノリン誘導体

Country Status (12)

Country Link
US (1) US9206130B2 (cg-RX-API-DMAC7.html)
EP (1) EP2262772B8 (cg-RX-API-DMAC7.html)
JP (1) JP5746015B2 (cg-RX-API-DMAC7.html)
KR (1) KR101325237B1 (cg-RX-API-DMAC7.html)
CN (1) CN102131783A (cg-RX-API-DMAC7.html)
AU (1) AU2009237938A1 (cg-RX-API-DMAC7.html)
CA (1) CA2718538A1 (cg-RX-API-DMAC7.html)
ES (1) ES2391373T3 (cg-RX-API-DMAC7.html)
IL (1) IL208103A (cg-RX-API-DMAC7.html)
MX (1) MX2010011224A (cg-RX-API-DMAC7.html)
RU (1) RU2010146474A (cg-RX-API-DMAC7.html)
WO (1) WO2009127417A1 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2311809A1 (en) * 2009-10-16 2011-04-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Quinolinyloxyphenylsulfonamides
EP2423208A1 (en) 2010-08-28 2012-02-29 Lead Discovery Center GmbH Pharmaceutically active compounds as Axl inhibitors
ITRM20100537A1 (it) 2010-10-12 2012-04-12 Consiglio Nazionale Ricerche Aptamero inibitore del recettore tirosina chinasi axl per uso in terapia
PT2780338T (pt) 2011-11-14 2017-02-17 Ignyta Inc Derivados de uracil como inibidores da quinase axl e c-met
JP6006241B2 (ja) 2012-01-31 2016-10-12 第一三共株式会社 ピリドン誘導体
CA2879542A1 (en) 2012-07-25 2014-01-30 Salk Institute For Biological Studies Regulating the interaction between tam ligands and lipid membranes with exposed phosphatidylserine
TWI649308B (zh) 2013-07-24 2019-02-01 小野藥品工業股份有限公司 喹啉衍生物
CN105916506B (zh) 2013-11-20 2020-01-07 圣诺康生命科学公司 作为tam家族激酶抑制剂的喹唑啉衍生物
CA2922542A1 (en) * 2013-11-22 2015-05-28 University Of Kentucky Research Foundation Arylquinoline and analog compounds and use thereof to treat cancer
EP3074390B1 (en) 2013-11-27 2020-07-08 SignalChem Lifesciences Corporation Aminopyridine derivatives as tam family kinase inhibitors
TWI723572B (zh) 2014-07-07 2021-04-01 日商第一三共股份有限公司 具有四氫吡喃基甲基之吡啶酮衍生物及其用途
US10208034B2 (en) 2014-12-25 2019-02-19 Ono Pharmaceutical Co., Ltd. Quinoline derivative
US9840503B2 (en) 2015-05-11 2017-12-12 Incyte Corporation Heterocyclic compounds and uses thereof
WO2017027717A1 (en) 2015-08-12 2017-02-16 Incyte Corporation Bicyclic fused pyrimidine compounds as tam inhibitors
US10053465B2 (en) 2015-08-26 2018-08-21 Incyte Corporation Pyrrolopyrimidine derivatives as TAM inhibitors
WO2017146236A1 (ja) 2016-02-26 2017-08-31 小野薬品工業株式会社 Axl阻害剤と免疫チェックポイント阻害剤とを組み合わせて投与することを特徴とする癌治療のための医薬
KR102558066B1 (ko) 2016-03-28 2023-07-25 인사이트 코포레이션 Tam 억제제로서 피롤로트리아진 화합물
CN108250200A (zh) * 2016-12-28 2018-07-06 中国科学院上海药物研究所 一种具有Axl抑制活性的化合物及其制备和应用
WO2018139527A1 (ja) 2017-01-26 2018-08-02 小野薬品工業株式会社 キノリン誘導体のエタンスルホン酸塩
WO2019039525A1 (ja) 2017-08-23 2019-02-28 小野薬品工業株式会社 Axl阻害剤を有効成分として含むがん治療剤
SG11202001664VA (en) * 2017-08-31 2020-03-30 Abbvie Inc Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereof
IL273579B2 (en) 2017-09-27 2025-10-01 Incyte Corp Salts of pyrrolizidine derivatives used as Tm inhibitors.
WO2019074116A1 (ja) 2017-10-13 2019-04-18 小野薬品工業株式会社 Axl阻害剤を有効成分として含む固形がん治療剤
HRP20250676T1 (hr) 2018-06-29 2025-08-01 Incyte Corporation Formulacije inhibitora axl/mer
BR112021018168B1 (pt) 2019-03-21 2023-11-28 Onxeo Composição farmacêutica, combinação e kit compreendendo uma molécula dbait e um inibidor de quinase para o tratamento de câncer
KR20220098759A (ko) 2019-11-08 2022-07-12 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) 키나제 억제제에 대해 내성을 획득한 암의 치료 방법
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
CN115697343A (zh) 2020-03-06 2023-02-03 因赛特公司 包含axl/mer和pd-1/pd-l1抑制剂的组合疗法
AU2021268210A1 (en) * 2020-05-08 2022-12-15 Georgiamune, Inc. Akt3 modulators
JP2022104746A (ja) * 2020-12-29 2022-07-11 国立研究開発法人国立がん研究センター 抗がん剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9510757D0 (en) * 1994-09-19 1995-07-19 Wellcome Found Therapeuticaly active compounds
EP1153920B1 (en) * 1999-01-22 2003-10-29 Kirin Beer Kabushiki Kaisha Quinoline derivatives and quinazoline derivatives
US7041691B1 (en) * 1999-06-30 2006-05-09 Amgen Inc. Compounds for the modulation of PPARγ activity
AU2003280599A1 (en) * 2002-10-29 2004-05-25 Kirin Beer Kabushiki Kaisha QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
ES2436888T3 (es) * 2003-09-26 2014-01-07 Exelixis, Inc Moduladores c-Met y métodos de uso
GB0509227D0 (en) * 2005-05-05 2005-06-15 Chroma Therapeutics Ltd Intracellular enzyme inhibitors
US20100234371A1 (en) * 2005-08-22 2010-09-16 Frank Himmelsbach Bicyclic heterocycles, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof
CA2655128A1 (en) * 2006-06-08 2007-12-21 Array Biopharma Inc. Quinoline compounds and methods of use
PL2101759T3 (pl) * 2006-12-14 2019-05-31 Exelixis Inc Sposoby stosowania inhibitorów MEK

Similar Documents

Publication Publication Date Title
JP2011517689A5 (cg-RX-API-DMAC7.html)
RU2010146474A (ru) Производные хинолина в качестве ингибиторов axl киназ
JP2013525293A5 (cg-RX-API-DMAC7.html)
JP4731114B2 (ja) 置換スルホンアミド化合物、cns障害、肥満およびii型糖尿病の処置のための医薬としてのそれらの使用方法
RU2394021C2 (ru) Новое производное антраниловой кислоты или его соль
JP2005526056A (ja) フタルイミドカルボン酸誘導体
US20220227732A1 (en) Pyridine carboxamide compounds for inhibiting nav1.8
ES2297382T3 (es) Derivados de sulfonamida como moduladores de ppar.
RU2576036C2 (ru) Модуляторы активности нес1 и способы для них
RU2563639C2 (ru) Замещенные соединения амида
CA3025887C (en) Sulfonamide compound or salt thereof
EP2074089A2 (en) Organic compounds
RU2008112184A (ru) Производное тиазола
CA2757761A1 (en) Sulfamoyl benzoic acid derivatives as trpm8 antagonists
AU2007282465C1 (en) Sulfonamide compound or salt thereof
US20070276011A1 (en) Plasminogen Activator Inhibitor-1 Inhibitor
JP2008545686A5 (cg-RX-API-DMAC7.html)
RU2007100229A (ru) Производные сульфонамида
RU2460723C2 (ru) Производные 4-(1-аминоэтил)циклогексиламина
RU2006116421A (ru) Анилиды салициловой кислоты
RU2013120137A (ru) Производные тетрагидрохинолина в качестве активаторов амрк
CA2628875A1 (en) Diaryl ureas for treating diabetic neuropathy
RU2017115036A (ru) Производные бензилгидроксида, их получение и их терапевтическое применение
MXPA06006211A (en) Biaryl sulfonamides as mmp inhibitors